FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W144335722> ?p ?o ?g. }

• W144335722 endingPage "460" @default.
• W144335722 startingPage "451" @default.
• W144335722 abstract "OBJECTIVE To evaluate: i. long-term efficacy of tamsulosin in the control of lower urinary tract symptoms (LUTS) suggestive of benign prostatic obstruction (BPO) using the I-PSS questionnaire, ii. the frequency of complications related to the disease, and iii. short and long-term tolerability of tamsulosin. METHODS A total of 2.921 patients with LUTS suggestive of BPO for more than 6 months and total IPSS > 7 treated with tamsulosin (Omnic) in real life practice conditions in Spain entered an observational prospective multicentre clinical study. Efficacy was primarily assessed by changes from baseline to endpoint in I-PSS symptoms score (total, irritative and obstructive), and secondarily by the appearance of disease complications, and urinary flow measurements. Safety was assessed recording every suspected adverse reaction, blood pressure changes and laboratory data on months 6 and 12. Evolution in time of free flow and sonographical evaluation of the prostate were also obtained in 663 (22.7%) and 1346 (46.1%) cases, respectively, and the use of previous and concomitant medication was also analysed. RESULTS After 6 and 12 months total I-PSS, irritative, and obstructive symptoms were significantly reduced with the use of tamsulosin 0,4 mg once daily. At 1 year follow-up total I-PSS score, irritative symptoms, and obstructive symptoms were reduced in 8.2, 3.5 and 4.8 points 146%, 45% and 48% improvement), respectively (p < 0.0001). The proportion of patients seriously symptomatic (total I-PSS score 20-35) was reduced from 34.8% at the start of the study to 8% at 6 months and 2.9% at 12 months. Mean QoL also significantly improved after 6 and 12 months of treatment. Average score QoL index was reduced from 4.1 to 1.86 after 12 months (2.24 points, 55% improvement) (p < 0.0001). Qmax also significantly improved after 6 and 12 months of treatment (p < 0.0001). The good tolerability profile of tamsulosin has been confirmed after 6 and 12 months of treatment. CONCLUSIONS Therapeutic intervention with tamsulosin 0,4 mg once daily is effective in all parameters analysed (I-PSS questionnaire and flow study), very well tolerated and safe in the short-term (6 and 12 months) in patients with LUTS suggestive of BPO. Long-term data specifically regarding the decrease in prostate volume and the evolution of the BPH condition will be welcome." @default.
• W144335722 created "2016-06-24" @default.
• W144335722 creator A5020757811 @default.
• W144335722 creator A5024588168 @default.
• W144335722 creator A5035987194 @default.
• W144335722 creator A5047138670 @default.
• W144335722 creator A5067405436 @default.
• W144335722 date "2004-05-01" @default.
• W144335722 modified "2023-09-27" @default.
• W144335722 title "Long-term study to assess the efficacy of tamsulosin in the control of symptoms and complications developed in patients with symptomatic benign prostatic hyperplasia (OMNICONTROL study): first-year follow-up report." @default.
• W144335722 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15270291" @default.
• W144335722 hasPublicationYear "2004" @default.
• W144335722 type Work @default.
• W144335722 sameAs 144335722 @default.
• W144335722 citedByCount "2" @default.
• W144335722 crossrefType "journal-article" @default.
• W144335722 hasAuthorship W144335722A5020757811 @default.
• W144335722 hasAuthorship W144335722A5024588168 @default.
• W144335722 hasAuthorship W144335722A5035987194 @default.
• W144335722 hasAuthorship W144335722A5047138670 @default.
• W144335722 hasAuthorship W144335722A5067405436 @default.
• W144335722 hasConcept C121608353 @default.
• W144335722 hasConcept C126322002 @default.
• W144335722 hasConcept C126894567 @default.
• W144335722 hasConcept C141071460 @default.
• W144335722 hasConcept C159110408 @default.
• W144335722 hasConcept C188816634 @default.
• W144335722 hasConcept C197934379 @default.
• W144335722 hasConcept C203092338 @default.
• W144335722 hasConcept C23131810 @default.
• W144335722 hasConcept C2776235491 @default.
• W144335722 hasConcept C2777562237 @default.
• W144335722 hasConcept C2778375690 @default.
• W144335722 hasConcept C2779384505 @default.
• W144335722 hasConcept C2779478474 @default.
• W144335722 hasConcept C2779951463 @default.
• W144335722 hasConcept C2780542891 @default.
• W144335722 hasConcept C535046627 @default.
• W144335722 hasConcept C71924100 @default.
• W144335722 hasConcept C77411442 @default.
• W144335722 hasConceptScore W144335722C121608353 @default.
• W144335722 hasConceptScore W144335722C126322002 @default.
• W144335722 hasConceptScore W144335722C126894567 @default.
• W144335722 hasConceptScore W144335722C141071460 @default.
• W144335722 hasConceptScore W144335722C159110408 @default.
• W144335722 hasConceptScore W144335722C188816634 @default.
• W144335722 hasConceptScore W144335722C197934379 @default.
• W144335722 hasConceptScore W144335722C203092338 @default.
• W144335722 hasConceptScore W144335722C23131810 @default.
• W144335722 hasConceptScore W144335722C2776235491 @default.
• W144335722 hasConceptScore W144335722C2777562237 @default.
• W144335722 hasConceptScore W144335722C2778375690 @default.
• W144335722 hasConceptScore W144335722C2779384505 @default.
• W144335722 hasConceptScore W144335722C2779478474 @default.
• W144335722 hasConceptScore W144335722C2779951463 @default.
• W144335722 hasConceptScore W144335722C2780542891 @default.
• W144335722 hasConceptScore W144335722C535046627 @default.
• W144335722 hasConceptScore W144335722C71924100 @default.
• W144335722 hasConceptScore W144335722C77411442 @default.
• W144335722 hasIssue "4" @default.
• W144335722 hasLocation W1443357221 @default.
• W144335722 hasLocation W1443357222 @default.
• W144335722 hasOpenAccess W144335722 @default.
• W144335722 hasPrimaryLocation W1443357221 @default.
• W144335722 hasRelatedWork W1554249994 @default.
• W144335722 hasRelatedWork W1567665160 @default.
• W144335722 hasRelatedWork W1900452780 @default.
• W144335722 hasRelatedWork W197993433 @default.
• W144335722 hasRelatedWork W1985776475 @default.
• W144335722 hasRelatedWork W2007291876 @default.
• W144335722 hasRelatedWork W2013892513 @default.
• W144335722 hasRelatedWork W2094711407 @default.
• W144335722 hasRelatedWork W2111264969 @default.
• W144335722 hasRelatedWork W2117332948 @default.
• W144335722 hasRelatedWork W2359516050 @default.
• W144335722 hasRelatedWork W2370324766 @default.
• W144335722 hasRelatedWork W2414560120 @default.
• W144335722 hasRelatedWork W2589035890 @default.
• W144335722 hasRelatedWork W2786468047 @default.
• W144335722 hasRelatedWork W3042317526 @default.
• W144335722 hasRelatedWork W3112191666 @default.
• W144335722 hasRelatedWork W3158502708 @default.
• W144335722 hasRelatedWork W3202390542 @default.
• W144335722 hasRelatedWork W2187208228 @default.
• W144335722 hasVolume "57" @default.
• W144335722 isParatext "false" @default.
• W144335722 isRetracted "false" @default.
• W144335722 magId "144335722" @default.
• W144335722 workType "article" @default.